IRCT138903244176N1已完成未知
The effects of metformin on anthropometric, metabolic and hormonal changes in polycystic ovarian syndrome
Hamedan university of medical sciences/Pro vice chancellor for research0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 45 years（—）
- 性别
- Female
入选标准
- •Reproductive age women referred due to infertility. Polycystic ovarian syndrome was defined as the presence of more than 12 cysts, 2–9 mm in diameter in one plane in at least one ovary and increased stroma, usually combined with increased ovarian volume >10 ml in sonography and clinical or biochemical hyperandrogenism. Subjects should have normal prolactin, thyroid, renal and hematological indices. No participant had received metformin or other hormonal treatment within the 3 months prior to study. Exclusion criteria included concurrent hormone therapy within the previous 6 weeks, any chronic disease that could interfere with the absorption, distribution, metabolism or excretion of metformin, renal or liver disease, being an smoker, doing intense physical activity, having lost 3 kg of body weight in the 2 months preceding the study
排除标准
- 未提供
研究者
相似试验
招募中
2 期
The effect of Metformin on complication of strokesStroke.Stroke, not specified as haemorrhage or infarctionIRCT20160318027097N5Vice Chancellor for research of Ardebil University of Medical Sciences100
已完成
2 期
Investigating the effect of metformin on the activity of systemic lupus erythematosusIRCT20220817055730N1Ahvaz University of Medical Sciences64
已完成
2 期
Effect of metformin on lung function in diabetic or prediabetic individuals with respiratory diseaseInsulin resistanceACTRN12610000378022Dr Paul Sexton40
进行中（未招募）
1 期
The effect of metformin on weight and cardiovascular risk markers in abdomenally obese subjects with impaired fasting glucose previously treated for 12 months with either rimonabant or placebo - Use of Metformin following weight loss and improvement in CV riskImpaired fasting glucoseMedDRA version: 9.1Level: LLTClassification code 10056997Term: Impaired fasting glucoseEUCTR2008-004497-40-GBHull and East Yorkshire Hospitals NHS Trust
招募中
3 期
Effects of metformin and lifestyle modifications on the progression of the atherosclerosis among individuals with impaired glucose tolerancePre-diabetesSLCTR/2016/026niversity Grants Commission, Sri Lanka